Introduction {#S1}
============

Microvascular tissue transfer is the first choice in the oral cavity reconstruction, especially in oncological resection [@R01]. The efficacy of this technique has progressively increased during years [@R02] [@R03]: improvements in optical technologies, surgeons\' attitudes and confidence with head and neck microvascular reconstruction and all its anatomical variations [@R04], in association with accurate patient selection have led to a global survival rate of 95-99% [@R05].

Despite this enormous success, there are still some unpredictable causes of failure: among thrombotic events, heparin- induced thrombocytopenia and thrombosis (HITT) represents a dramatic condition that is frequently misrecognised and consequently, very difficult to treat in a timely manner [@R06]^-^[@R12]. HITT has devastating outcomes and greater information and understanding are needed about the condition: until now, only 8 papers have been published in the English literature: herein we report our experience on HITT through presentation of a case report.

We conducted a research on PubMed focusing on 2 keywords \"HITT/HIT + microvascular free flap reconstruction\" and we found 6 publications and 1 systematic review reporting a total of 9 cases of HITT in microvascular surgery ([Table I](#T1){ref-type="table"}), confirming that HITT is not a widely documented condition in the medical literature. In 2008, Tremblay et al. [@R06] described 2 cases of HITT in heparin naïve patients, both confirmed by positive anti-heparin antibody tests. They both suffered from venous congestion within hours following the intervention (respectively at 26 and 48 hours) after having received unfractioned heparin (UFH). The first case was treated with leeches and anticoagulation therapy (argatroban) for about 1 month until he had a total free flap loss. In the second case, heparin was stopped promptly and danaparoid sodium was started, which worked adequately.

###### 

Literature review.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author,\     Number\      Clinical\           Onset time         Time\         Pre-hitt\         Post-hitt\           Hitt therapy      Previous\     Confirmation\
  year         of\          manifestation\                         to hitt\      therapy           therapy                                herapin\      of Hitt by\
               patients     (arterious,\                           diagnosis                                                              exposure      antibody test
                            venous)                                                                                                                     
  ------------ ------------ ------------------- ------------------ ------------- ----------------- -------------------- ----------------- ------------- -----------------
  Tremblay,\   2            Case 1: venous\     Case 1: 26\        Case 1: 12\   Case 1:\          Case 1:\             Case 1:\          Case 1: no\   Case 1 & 2: yes
  2008                      congestion\         hours\             days\         Heparin 5000\     heparinised\         Heparin\          Case 2:\      
                            Case 2: venous\     Case 2: 48\        Case 2: 11\   U sc twice\       gauzes,\             discontinued,\    unknown       
                            congestion          hours              days          daily\            Leeches,\            Argatroban\                     
                                                                                 Case 2:\          Heparin\             Case 2:\                        
                                                                                 Heparin 5000\     perfusion\           Heparin\                        
                                                                                 U sc twice\       Case 2:\             discontinued,\                  
                                                                                 daily, ASA 80\    continuous\          Orgaran for\                    
                                                                                 mg daily          heparin infusion,\   17 days                         
                                                                                                   Heparin 6000\                                        
                                                                                                   U boluses,\                                          
                                                                                                   Leeches                                              

  Schleich,\   1            Venous\             6 hours            6 hours       Systemic\         IV derapi\           Heparin\          Unknown       Yes
  2008                      thrombosis,\                                         herapinisation    perfusion            discontinued,\                  
                            decreased\                                                                                  Argatroban\                     
                            doppler sign                                                                                for 5 days,\                    
                                                                                                                        long term\                      
                                                                                                                        Warfarin for 3\                 
                                                                                                                        months                          

  Busch,\      2            Case 1:\            Case 1: 12\        Case 1:\      Case 1:\          Case 1:\             Case 1:\          Case 1:\      Case 1 & 2: yes
  2009                      malperfusion\       hours\             unknown\      unknown\          unknown\             Heparin\          unknown\      
                            Case 2: arterial\   Case 2:\           Case 2:\      Case 2:\          Case 2:\             discontinued,\    Case 2:\      
                            thrombosis          referred\          unknown       unknown           unknown              Lepirudin\        yes           
                                                from another\                                                           Case 2:\                        
                                                hospital                                                                Heparin\                        
                                                                                                                        discontinued,\                  
                                                                                                                        Lepirudin                       

  McCleave,\   1            Venous\             5 days             6 days        LMWH preop,\      Heparin infusion     Heparin\          No            Antibody test\
  2010                      congestion and\                                      Heparin\                               discontinued,\                  negative,\
                            thrombosis,\                                         5000 U                                 Lepirudin,\                     but platelet\
                            venous\                                                                                     long term\                      aggregation\
                            and arterial\                                                                               Warfarin                        assay positive
                            thrombosis                                                                                                                  

  Medina,\     1, 2 flaps   1st flap:\          st flap: 4 days\   12 days       ASA, Lovenox      Heparin 5000 U\      Heparin\          Unknown       No. HITT\
  2010                      venous\             2nd flap: 1\                                       boluses              discontinued,\                  confirmed by\
                            congestion,\        day                                                                     Leeches,\                       hypercoaguable\
                            necrotic tissue\                                                                            Argatroban,\                    workup
                            2nd flap:\                                                                                  long term\                      
                            venous\                                                                                     Coumadin                        
                            congestion                                                                                                                  

  Tessler,\    1, 2 flaps   1st flap:\          Immediately\       6 days        Heparin drips,\   tPA 6 mg\            Heparin\          Unknown       Yes
  2013                      venous\             compromised,\                    leeches           in a close\          discontinued,\                  
                            congestion,\        1st flap\                                          loop circuit,\       fondaparinux,\                  
                            decreased\          failure: 2 days\                                   Enoxaparin 40\       long term\                      
                            doppler sign\       2nd flap\                                          mg sc daily          Warfarin                        
                            2nd flap:\          failure: 6 days                                                                                         
                            arterial\                                                                                                                   
                            thrombosis                                                                                                                  

  Zaman,\      1            Arterial\           6 hours            Unknown       Unknown           Heparin 5000 U\      Heparin\          Unknown       Yes
  2014                      thrombosis                                                             iv, Heparin 5000\    discontinued,\                  
                                                                                                   U twice daily        Danaparoid\                     
                                                                                                                        infusion                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Schleich et al. [@R07] reported a case of HITT in a patient treated with a latissimus dorsi flap with an unknown story of heparin exposure. Six hours after surgery a decreased arterial Doppler signal, platelet count drop and positive antibody test confirmed a suspicion of HITT. Heparin was interrupted and anticoagulation was switched to argatroban. Warfarin was mandatory as long term therapy.

In 2009, Busch et al. [@R08] published 2 cases of HITT with a total flap loss with early onset, recurrent arterial thrombosis and no significant decrease in platelets. In the first case, HITT was diagnosed 12 hours post-operatively and was confirmed by positive antibody test in a patient with previous heparin exposure. Microvascular anastomoses were unsuccessfully revised 12 times. The second case reported was a flap failure due to HITT that occurred at an unknown period after surgery. HITT antibodies were positive and heparin was immediately stopped and changed into lepirudin; the defect was reconstructed with a second free flap 10 days after heparin suspension.

McCleave et al. [@R09] published a paper in 2010 describing the case of a heparin naïve patient which had both an arterial and a venous congested flap 5 days after surgery with a negative antibody test and a positive platelet aggregation assay. He was unsuccessfully treated with exploration, heparin was interrupted and lepirudin was initiated. Warfarin was also mandatory as long-term therapy in this case.

In 2010 a paper by Medina et al. [@R10] reported the failure of 2 free flaps due to HITT in the same patient with unknown prior heparin exposure. Four days after performing the 1^st^ flap, a second one was done. Venous congestion was noted immediately in the 2^nd^ flap, which was successfully treated with leeches and argatroban. HITT was diagnosed thanks to a hypercoagulability workup.

Tessler et al. [@R11] in their review in 2013 analysed the literature by dividing papers in 3 groups: prior heparin exposure, heparin naive and prior heparin status not discussed. In each group, the number of patients, HITT flap characteristics, time until flap failure, treatment of HITT and confirmation of HITT by antibody test were analysed. They also reported a case of an ALT flap failure 2 days after surgery in a patient with a chronic right malleolus wound and no story of previous heparin exposure. Anastomosis were revised twice and a therapy with tPA in the operating theatre and leeches afterward was used, and starting on the 4^th^ day RFFF was performed and persisted with good perfusion for 4 days. Thrombosis manifested again: thrombolysis with tPA and attempt of re-anastomosis were done unsuccessfully; the final decision was positioning a vacuum assisted closure therapy. HITT was diagnosed afterwards using an ELISA test and heparin was immediately stopped in favour of fondaparinux. Despite anticoagulant therapy, a trans-tibial amputation was needed because of deep venous thrombosis (DVT).

Zaman et al. [@R12] wrote a letter to the editor in 2014 to expose a case of a free gracilis flap partial failure 6 hours after surgery due to an arterial thrombosis, so the arterial anastomosis was revised. Post-operatively over the next few days the flap again showed signs of failure. At re-exploration, both the artery and vein were thrombosed and it was impossible to re-establish flow. The flap was removed, the wound debrided and a negative pressure dressing was applied. The platelet count was trending downward prior to the gracilis free flap. A diagnosis of HITT was considered and anti-heparin antibody assays were positive. Heparin was ceased and the patient was started on danaparoid infusion. The platelet count returned to normal limits within 3 days following cessation of heparin. Because of platelet count stability, his lower limb defect was reconstructed with a right latissimus dorsi free muscle flap. This second flap had an unremarkable post-operative course.

Case report {#S2}
===========

A 40-year-old non-smoking man, F.M., with no co-morbidities presented. He reported a fracture of the right knee, occurring 20 years ago; we after discovered that on this occasion he had had anti-thrombotic prophylaxis with sub-cutaneous heparin.

The patient came to our attention for squamous cell crcinoma (SSC) of the lateral border of the tongue (cT2N0), diagnosed in September 2015. We performed the usual pre-operative assessments (blood exam, ECG, chest radiograph, anaesthesiological evaluation) and no surgical contraindications were found. We performed partial glossectomy, selective neck dissection level I-III, and the defect was reconstructed with a left anterolateral thigh (ALT) flap. As per our routine, before cutting the descending branch of the deep circumflex artery, a heparin bolus was administered (2500 I.U.). The arterial and the two venous microanastomoses were performed on the superior thyroid artery and on the thyreolinguofacial trunk and on the superior thyroid vein, respectively. During the microsurgical time, the vessels were washed only with heparinised solution. Intra-operative angiography with indocyanine green was negative. The surgery was carried out unremarkably, and no surgical or anaesthesiological problems were seen. As per routine, we prescribed nadroparin 4000 I.U. daily. About 24 hours after surgery the flap appeared mildly congested, and application of medical leeches was initiated. We continued with hourly flap monitoring, but the clinical suspicion of mild-to moderate congestion persisted. On the morning of the 2nd post-operative day the flap colour had turned to blue, the temperature was decreased and the blood color, at the puncture, was quite dark: the patient was thus returned to the operating theatre. As expected, multiple venous thrombi were detected while the arterial flow was still valid. We attempted to remove the thrombi with direct administration of fibrinolytic drugs (6 mg of tissue plasminogen activator \[tPa\]) and by mechanical thrombolysis with a Fogarty catheter. Both maneuvers were relatively ineffective: the artery was still working, but without venous drainage. The flap appeared to be irrecoverable, so we removed the ALT flap and reconstructed the tongue defect with a left radial forearm free flap (RFFF): the microvascular anastomoses were performed again on the superior thyroid artery and the internal jugular vein, in a termino-lateral fashion. Vessel patency was tested with indocyanine green. The RFFF showed a good perfusion for about 24 hours; unfortunately, impairment of the venous drainage was noted on post-operative day 3. The patient was returned to the operating theatre again. At surgical exploration, we discovered the left internal jugular vein completely occluded by thrombi. We tried once again to remove the thrombi, but they continued to reform intraoperatively and it was not possible to re-establish venous flow. The flap appeared still alive and so we performed a second venous anastomosis on the superior thyroid vein ([Fig. 1](#F1){ref-type="fig"}). At the end of this third surgery, the flap perfusion was good and continuous heparin infusion had been started to contrast thrombophilia. During these 72 hours, blood exam, coagulation test and platelet counts did not show significant alterations ([Fig. 2](#F2){ref-type="fig"}), and the patient\'s general conditions were good. After about 24 hours of intravenous heparin (3000 I.U./day), haematomas formed in each surgical site (left thigh, left forearm, left neck): we evacuated the cervical and the antebrachial haematomas in the operating room. The flap perfusion continued well, the forearm skin was pink and no stasis was detected ([Fig. 3](#F3){ref-type="fig"}). The situation worsened on the 5th post-operative day: the RFFF started to suffer, it became blue ([Fig. 4](#F4){ref-type="fig"}) and, in addition to the local problem, systemic manifestations showed: venous accesses, both peripheral and central, did not work and the blood in drainage sack coagulated very quickly. We performed another surgery: the forearm flap appeared very congested, we tried once again to restore venous flow, but every attempt was unsuccessful. We finally decided to remove the flap and to change the reconstructive technique: the wound was closed with a facial artery myo-mucosal (FAMM) flap.

![Radial forearm free flap well perfused.](0392-100X-36-527-g001){#F1}

![Platelet profile during post-op days.](0392-100X-36-527-g002){#F2}

![Radial forearm free flap, after the second re-exploration.](0392-100X-36-527-g003){#F3}

![Venous stasis of the radial forearm free flap.](0392-100X-36-527-g004){#F4}

A haematologist was consulted and specific coagulation tests were performed: on the morning of the 6th postoperative day we received the results: heparin-PF4 antibodies resulted positive by enzyme-linked immunoassay (ELISA). The haematologist rendered a diagnosis of HITT. We promptly substituted low body weight heparin (LBWH) with fondaparinux, a synthetic heparin- like polysaccharide targeting only the coagulation factor Xa and without affinity for PF4, avoiding the formation of heparin/PF4 antibody complexes. In the following days, the platelet count, which had dropped at least at 120x10^9^ at the apex of the manifestations on the 5th day, increased to 483-529 x 10^9^, further supporting a diagnosis of HITT. The patient\'s recovery continued without complications, and the fondaparinux dose was increased up to 7.5 mg/day. He was discharged on the 21th day after the first surgery; 3 weeks later the autonomization of the pedicled flap was accomplished without further complications.

Discussion {#S3}
==========

HITT is a syndrome caused by the presence of antibodies linked to complex platelet factor 4 (PF4), which are exposed after heparin linkage. Among all antibodies, IgG are those that provoke platelet activation and aggregation, leading to thrombocytopenia and, in 50% of cases, thrombotic events. A diagnosis of thrombocytopenia is made when the platelets count is less than 150,000/mm^3^ or when the decrease is more than 50%; the thrombotic events usually involve veins, with a venous:arterious ratio of 4:1 [@R13]. HITT manifests in two different forms. Type 1 depends on the direct activation of platelet heparin-mediated and is asymptomatic: thrombocytopenia resolves spontaneously in 1-2 days, normally without thrombotic events, and no intervention is usually required [@R14]. HITT type 2 is platelet activation mediated by immuno-complex [@R15]: it manifests later, usually in 4-10 days after heparin exposure and thrombotic events are co-existing, usually involving organs or tissues with pre-existing endothelial injury 16; there is also a so-called \"local-form\" characterised by flap loss occurring very early in the post-operative course, with no drop in platelet counts [@R08]. The risk of developing HITT is correlated to the type of heparin: the major risk is with bovine heparin and with LBWH. The antibodies completely disappear in 100 days [@R17]. Rapid diagnosis of HITT is challenging: it manifests in unexpected ways, it\'s hard to recognise and unfortunately the consequences of diagnostic delay can be dramatic: flow impairment to the flap can result in flap loss, nullifying the efficacy of the surgery [@R18]. Typically heparin prophylaxis is administered to prevent venous flow impairment; when venous suffering is recognised, leech therapy is usually introduced, and can gradually resolve the situation. If leeches do not work, surgical revision is required: during surgery it is possible to directly see anastomosis, remove thrombi and locally administer fibrinolytic drugs, such as t-PA.

There is no general consensus about thrombosis prevention [@R19], but heparin therapy still remains a cornerstone during postoperative microsurgery: the paradox is that the therapy is the cause of the thrombosis, and this explains the difficulty in diagnosing HITT. Laboratory tests typically show thrombocytopenia after clinical manifestations that could be referred to other causes; systemic manifestations of thrombosis do not manifest, sustaining the probability of a local problem. Furthermore, routine anamnesis does not investigate prior heparin therapy, and even if well investigated, prior assumption of heparin is not an essential diagnostic information because it could occur even in heparin naive patients [@R09].

When the microsurgeon has to face venous drainage complications the first doubt is technical error [@R20]. In routine surgical activity, local problems are more easily believed to be the cause of venous congestion, more than a misdiagnosed systemic condition. All these aspects clarify the problems in HITT diagnosis: the time gap between the first clinical sign and diagnosis is usually enough to lead to irrecoverable damage ([Table I](#T1){ref-type="table"}). Hypercoagulability state, hereditary or acquired, is quite frequent in the general population and unrecognised coagulopathies represent a significant cause of flap failure [@R21]. We also have to consider the typology of patient undergoing reconstruction in head and neck surgery: the patient is usual oncological, as in our case, and frequently is a heavy smoker: both these factors increase propensity to clot formation. Furthermore, microsurgery itself may concur to thrombosis: the handling of vessels, with micro-damage on the endothelium, and the long surgical time, with prolonged immobilisation, may play a role in thrombotic aetiology. Dramatic outcomes in free flap surgery due to unpredictable thrombotic events are reported in the literature: from the experience with unknown coagulopathic patients the importance of specific anamnesis can be recognised, investigating about thrombophilia, not only in the patient but also in the family [@R22]; differently, the patient at risk for HITT cannot be recognised previously: the search for antibodies cannot be routinely performed and is not useful because they disappear at about 100 days after the manifestations; perhaps the only useful anamnestic data is previous exposure to heparin but, as already mentioned, is not specific for HITT diagnosis. Diagnosis is assessed only with a laboratory test that should be requested as soon as possible in order to break the chain of events: a prompt suspicion of HITT may be helpful in reducing negative outcomes. Warkentin and Heddle suggested a pre-lab test score (\"4T score\") [@R23]: clinical data and lab exam determine the grade of risk for HITT ([Table II](#T2){ref-type="table"}): evidence of a low score demonstrates unlikely HITT (\< 5%), an intermediate score (4-5) has a clinical profile of HITT, but alternative explanations may still be relevant, and finally a high score representing a likely case of HITT (\> 80%). This clinical score has been evaluated by both prospective and retrospective studies and has been demonstrated to have a predictive negative value (PNV) of 100% [@R24]. Whenever thrombotic complications occur HITT diagnosis should be considered, and this clinical test should be kept in mind as it allows addressing suspicions toward intrinsic alterations in coagulation.

###### 

4T score.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------
  4T\'s                              0 POINT                                  1 POINT                                   2 POINT
  ---------------------------------- ---------------------------------------- ----------------------------------------- ------------------------------------------
  Thrombocytopenia                   \< 30% platelet count fall or \< 10 x\   A 30-50% decrease in platelet\            \> 50% fall in platelet count or nadir\
                                     10^9^/L platelet nadir                   count or platelet nadir 10-20 x 10^9^/L   2-100 x 10^9^/L

  Timing of platelet count fall      Early drop (\< 4 days) in platelet\      Onset after 10 days, or some\             Clear onset between 5-10 days after\
                                     count in never exposed                   platelet count data missing               initiation of heparin, or platelet fall\
                                                                                                                        1 day

  Thrombosis \_ other sequela        None                                     Progressive or recurrent thrombosis       New thrombosis (confirmed), skin\
                                                                                                                        necrosis present, systemic reaction\
                                                                                                                        to heparin bolus

  Other causes of thrombocytopenia   Definite                                 Possible                                  No alternative explanation
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------

Conclusions {#S4}
===========

In reconstructive microsurgery unexpected thrombosis is a very serious complication that, if untreated, can lead to flap necrosis. A prompt and correct diagnosis followed by appropriate therapy is mandatory. The microsurgeon usually suspects technical error or some other local problem; systemic alterations are considered as a possible cause of thrombosis secondarily, also because routine coagulation tests are considered sufficient to discriminate coagulopathic patients. Furthermore, the absence of a general consensus about post-operative anticoagulation therapy complicates the management of thrombotic manifestations. The case presented summarises very well as diagnosis of HITT is difficult: a healthy young patient, non-smoker, silent anamnesis, platelet count and PT and PTT in normal range and the onset of haemorrhagic problems: all these aspects contribute to deviating one\'s attention. The result was devastating: four re-exploration surgeries and two free flap failures. The 4T test could be a valid aid for HITT diagnosis because clinical evaluation alone is insufficient and laboratory confirmation requires cost and time. At present, the most useful and feasible tool for HITT suspicion is complete anamnesis investigating not only coagulopathic risk, as proposed by Friedman et al. [@R22], but also investigating prior heparin exposure ([Table III](#T3){ref-type="table"}).

###### 

Pre-operative assessment.

  Pre-op questionnaire
  -------------------------------------------------------------------------------------------
  1\. Have you or anyone in your family have had a blood clot?
  2\. Have you or anyone in your family ever been on blood thinners?
  3\. Have you or anyone in your family ever been diagnosed with a blood clotting disorder?
  4\. Has anyone in your family had a disease called *\"purpura fulminans\"*?
  5\. Have you ever been diagnosed with Lupus or anyother autoimmune disease?
  6\. For female patients: Have you ever had a miscarriage?
  7\. Have you ever been exposed to heparin?
